{{Rsnum
|rsid=2860174
|Gene=INSR
|Chromosome=19
|position=7130707
|Orientation=minus
|GMAF=0.186
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|effect1=
|effect2=
|effect3=
|Gene_s=INSR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 38.1 | 61.9
| HCB | 0.0 | 29.5 | 70.5
| JPT | 0.0 | 18.2 | 81.8
| YRI | 0.0 | 31.7 | 68.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 29.5 | 70.5
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}

A combined study totaling 1,000+ patients with [[migraine]] susceptibility concluded that even larger numbers of individuals are required to exclude or confirm the most likely small effect of [[rs2860174]] on migraine susceptibility.{{PMID|18455362}}

{{on chip | 23andMe v3}}